Lanreotide Acetate 69097-0880-67

Package NDC

69097-0880-67

Manufacturer: Cipla Usa Inc.
Dosage Form: Injection
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: December 24, 2021
Listing Expires: December 31, 2026
Application: NDA215395

Need to source Lanreotide Acetate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Lanreotide Acetate	60 mg/.2mL

Drug Class

Somatostatin Analog [EPC]Somatostatin Receptor Agonists [MoA]

Selected Package

69097-0880-67Selected

1 SYRINGE in 1 CARTON (69097-880-67) / .2 mL in 1 SYRINGE